Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)
SCHMOLL, Hans-Joachim, CUNNINGHAM, David, SALAZAR, Ramon, BARKER, Peter, MOOKERJEE, Bijoyesh, ROBERTSON, Jane, VAN CUTSEM, Eric, SOBRERO, Alberto, KARAPETIS, Christos S, ROUGIER, Philippe, KOSKI, Sheryl L, KOCAKOVA, Ilona, BONDARENKO, Igor, BODOKY, György, MAINWARING, Paul
Published in Journal of clinical oncology (10.10.2012)
Published in Journal of clinical oncology (10.10.2012)
Get full text
Journal Article
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study
Chen, Eric X, Jonker, Derek J, Loree, Jonathan M, Kennecke, Hagen F, Berry, Scott R, Couture, Felix, Ahmad, Chaudhary E, Goffin, John R, Kavan, Petr, Harb, Mohammed, Colwell, Bruce, Samimi, Setareh, Samson, Benoit, Abbas, Tahir, Aucoin, Nathalie, Aubin, Francine, Koski, Sheryl L, Wei, Alice C, Magoski, Nadine M, Tu, Dongsheng, O'Callaghan, Chris J
Published in JAMA oncology (01.06.2020)
Published in JAMA oncology (01.06.2020)
Get more information
Journal Article
Immunohistochemical Variation of Human Equilibrative Nucleoside Transporter 1 Protein in Primary Breast Cancers
MACKEY, John R, JENNINGS, Lori L, CASS, Carol E, CLARKE, Marilyn L, SANTOS, Cheryl L, DABBAGH, Laith, VSIANSKA, Michaela, KOSKI, Sheryl L, COUPLAND, Robert W, BALDWIN, Stephen A, YOUNG, James D
Published in Clinical cancer research (01.01.2002)
Get full text
Published in Clinical cancer research (01.01.2002)
Journal Article
Final Results of a Phase II Clinical Trial of Weekly Docetaxel in Combination with Capecitabine in Anthracycline-Pretreated Metastatic Breast Cancer
Mackey, John R., Tonkin, Katia S., Koski, Sheryl L., Scarfe, Andrew G., Smylie, Michael G.B., Joy, Anil A., Au, Heather-Jane, Bodnar, Dianne M., Soulieres, Denis, Smith, Stephanie W.
Published in Clinical breast cancer (01.10.2004)
Published in Clinical breast cancer (01.10.2004)
Get full text
Journal Article
Artemin and immune checkpoint inhibitor (ICI) efficacy in metastatic colorectal cancer (mCRC): A correlative analysis of the Canadian Cancer Trials Group (CCTG) CO.26 trial
Ma, Lucy Xiaolu, Titmuss, Emma, Jonker, Derek J., Kennecke, Hagen Fritz, Berry, Scott R., Couture, Felix, Ahmad, Chaudhary E., Goffin, John R., Kavan, Petr, Harb, Mohammed, Colwell, Bruce, Samimi, Setareh, Samson, Benoit, Abbas, Tahir, Aubin, Francine, Koski, Sheryl L., Tu, Dongsheng, O'Callaghan, Christopher J., Loree, Jonathan M., Chen, Eric Xueyu
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Plasma arginine as a candidate predictive biomarker for response to immune checkpoint inhibition (ICI) in metastatic colorectal cancer (mCRC): Analysis of the CCTG CO.26 trial
Ma, Lucy Xiaolu, Loree, Jonathan M., Jonker, Derek J., Kennecke, Hagen Fritz, Berry, Scott R., Couture, Felix, Ahmad, Chaudhary E., Goffin, John R., Kavan, Petr, Harb, Mohammed, Colwell, Bruce, Samimi, Setareh, Samson, Benoit, Abbas, Tahir, Aucoin, Nathalie, Aubin, Francine, Koski, Sheryl L., Tu, Dongsheng, O'Callaghan, Christopher J., Chen, Eric X
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Plasma phosphocreatine (PC) as a predictive biomarker for immune checkpoint inhibition in patients with refractory metastatic colorectal cancer (mCRC): Analysis of the CCTG CO.26 trial
Ma, Lucy Xiaolu, Loree, Jonathan M., Jonker, Derek J., Kennecke, Hagen Fritz, Berry, Scott R., Couture, Felix, Ahmad, Chaudhary E., Goffin, John R., Kavan, Petr, Harb, Mohammed, Colwell, Bruce, Samimi, Setareh, Samson, Benoit, Abbas, Tahir, Aucoin, Nathalie, Aubin, Francine, Koski, Sheryl L., Tu, Dongsheng, O'Callaghan, Christopher J., Chen, Eric Xueyu
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Effects of liver metastases on efficacy of immune checkpoint blockade in treatment refractory, metastatic colorectal cancer (CRC): CCTG CO.26
Chen, Eric Xueyu, Loree, Jonathan M., Tu, Dongsheng, O'Callaghan, Christopher J., Kennecke, Hagen Fritz, Jonker, Derek J., Chaudhary, Ahmad, Colwell, Bruce, Harb, Mohammed, Aucoin, Nathalie, Couture, Felix, Samimi, Setareh, Kavan, Petr, Aubin, Francine, Samson, Benoit, Goffin, John R., Berry, Scott, Abbas, Tahir, Koski, Sheryl L., Wei, Alice Chia-chi
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
The CCTG CO.26 trial: A phase II randomized study of durvalumab plustremelimumab and best supportive care (BSC) vs BSC alone in patients with advanced colorectal carcinoma (CRC) refractory to standard therapies
Chen, Eric Xueyu, Jonker, Derek J., Kennecke, Hagen F., Koski, Sheryl L., Wei, Alice Chia-chi, Magoski, Nadine M, Tu, Dongsheng, O'Callaghan, Christopher J.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
CCTG CO.26: Updated analysis and impact of plasma-detected microsatellite stability (MSS) and tumor mutation burden (TMB) in a phase II trial of durvalumab (D) plus tremelimumab (T) and best supportive care (BSC) versus BSC alone in patients (pts) with refractory metastatic colorectal carcinoma (rmCRC)
Chen, Eric Xueyu, Jonker, Derek J., Loree, Jonathan M., Kennecke, Hagen F., Berry, Scott R., Couture, Felix, Ahmad, Chaudhary E., Goffin, John R., Kavan, Petr, Harb, Mohammed, Colwell, Bruce, Samimi, Setareh, Samson, Benoit, Abbas, Tahir, Aucoin, Nathalie, Aubin, Francine, Koski, Sheryl L., Wei, Alice Chia-chi, Tu, Dongsheng, O'Callaghan, Christopher J.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
CCTG CO.26 trial: A phase II randomized study of durvalumab (D) plus tremelimumab (T) and best supportive care (BSC) versus BSC alone in patients (pts) with advanced refractory colorectal carcinoma (rCRC)
Chen, Eric Xueyu, Jonker, Derek J., Kennecke, Hagen F., Berry, Scott R., Couture, Felix, Ahmad, Chaudhary E., Goffin, John R., Kavan, Petr, Harb, Mohammed, Colwell, Bruce, Samimi, Setareh, Samson, Benoit, Abbas, Tahir, Aucoin, Nathalie, Aubin, Francine, Koski, Sheryl L., Wei, Alice Chia-chi, Magoski, Nadine M, Tu, Dongsheng, O'Callaghan, Christopher J.
Published in Journal of clinical oncology (01.02.2019)
Published in Journal of clinical oncology (01.02.2019)
Get full text
Journal Article
LAPACT: An open-label, multicenter phase II trial of nab -paclitaxel ( nab -P) plus gemcitabine (Gem) in patients (pts) with locally advanced pancreatic cancer (LAPC)
Philip, Philip Agop, Lacy, Jill, Dowden, Scot D., Sastre, Javier, Bathini, Venu Gopal, Cardin, Dana Backlund, Ma, Wen Wee, Sobrero, Alberto F., Koski, Sheryl L., Borg, Christophe, Tonini, Giuseppe, Rivera, Fernando, Hwang, Jimmy J., Knoble, Jeanna L., Al Baghdadi, Tareq, Saif, Wasif M., Meiri, Eyal, Kayitalire, Louis, Li, Jack, Hammel, Pascal
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article